Subscribe to our Newsletters !!

    Kumar Jeetendra

    Handling airborne transmission of COVID-19 inside

    Forestalling airborne transmission of Covid-19 ought to be the following front of the fight against the infection, contend specialists from the University of Surrey. In an investigation distributed by the City and Environment Interaction diary, researchers from Surrey’s Global Center for Clean Air Research (GCARE), along with accomplices from Australia’s Queensland University and Technology, contend

    Bayer Celebrates 60 Years of Progress in Empowering Women

    Mumbai, May 28, 2020: On the International Day of Action for Women’s Health, Bayer is celebrating the 60th anniversary of the Contraceptive Pill that has impacted millions of women across the globe. This pill has opened a world of opportunity by giving women and couples the right to have a child by choice, not chance.

    Corresponding Assessment Scenarios in Laboratory and on-Court Tests

    To the best of our knowledge, the present study is the first to relate physiological, mechanical and specific performance parameters in basketball using the complex networks model. Thus, this study focused efforts on comparing, by means of centrality metrics (degree, betweenness, eigenvector, and pagerank), tests that can successfully establish power, velocity, and force results in

    Advancement of pandemic coronavirus plots way from animals to humans

    A group of researchers considering the inception of SARS-CoV-2, the infection that has caused the COVID-19 pandemic, found that it was particularly appropriate to bounce from creatures to people by shapeshifting as it picked up the capacity to contaminate human cells. Directing a hereditary examination, specialists from Duke University, Los Alamos National Laboratory, the University

    Chinese firm Sinovac 99% sure COVID-19 antibody will work: Report

    Chinese biopharmaceutical organization Sinovac Biotech has said that it is 99% certain that their COVID-19 antibody will work. The organization arrived at stage 2 of the coronavirus antibody preliminary with in excess of 1000 volunteers taking part. The organization is in starter converses with hold stage 3 preliminaries – the last piece of the procedure

    Sun Pharma gets gesture for medicate trial in COVID-19 patients

    Sun Pharmaceutical Industries Ltd. has reported that it has gotten the endorsement from the Drugs Controller General of India (DCGI) to start a clinical preliminary with Nafamostat Mesilate in COVID-19 patients. Nafamostat is endorsed in Japan for development of intense side effects of pancreatitis and treatment of Disseminated Intravascular Coagulation (DIC). “A gathering of researchers